The Destination for Pharmacy Education

Harrison School of Pharmacy

Faculty and Staff Directory


Richard Hansen

Richard Hansen

Dean
Gilliland Professor
Units: Administration, Health Outcomes Research and Policy
Auburn University
Harrison School of Pharmacy
2316 Walker Building
Auburn, AL 36849
Email: rah0019@auburn.edu
Phone: 334-844-8348
Fax: 334-844-8307


Curriculum Vitae


Bio

Education:
  • B.S., Pharmacy - University of Wisconsin-Madison
  • Ph.D., Social, Administrative and Clinical Pharmacy - University of Minnesota-Twin Cities

Dr. Richard Hansen was announced as Dean of the Harrison School of Pharmacy on Jan. 20, 2017, taking over the role on May 15. He is the sixth Dean in the history of HSOP and takes the position after serving as Gilliland Professor and head of HSOP's Department of Health Outcomes Research and Policy since 2010.

Since arriving at Auburn, Hansen has worked to improve the school’s national prominence among leading pharmacy schools. As head of the Department of Health Outcomes Research and Policy, he worked to inspire research by demonstrating that obtaining funding was achievable. Hansen has submitted grant or contract applications totaling more than $20 million and has published more than 50 original research articles in peer reviewed journals while at Auburn. Every faculty member in the department currently has active extramural research funding. During this time, the department also implemented a new curriculum in health outcomes research.

After earning a bachelor’s degree in pharmacy from the University of Wisconsin-Madison, Hansen practiced in both hospital and retail pharmacy settings. The work inspired him to return to graduate school and learn how to create more effective, efficient and safer health care systems. He received a doctorate from the Social, Administrative and Clinical Pharmacy graduate program at the University of Minnesota in 2003.

From 2003-10, Hansen was an assistant (2003-08) and associate (2008-10) professor in the Division of Pharmaceutical Outcomes and Policy at the University of North Carolina-Chapel Hill Eshelman School of Pharmacy.


Licensure:

Registered Pharmacist, Alabama Board of Pharmacy
License Number: 20814

Registered Pharmacist, Wisconsin Department of Safety & Professional Services
License Number: 12702-40


Research Interests:

My work focuses on understanding and improving population-based health outcomes. I conduct studies in pharmacoepidemiology and health outcomes research to better understand how the benefits and harms of competing interventions or healthcare delivery models compare. My research also assesses factors influencing drug use, medication adherence, drug safety, and the effectiveness of practice-based interventions.ÊThe underlying goal of my research is to inform decision-making and policy through evaluation of healthcare interventions.


Funded Research:

1/1/21 – 12/31/23
Agency for Healthcare Research and Quality; Grant No: U18 HS27946-01
The Alabama Cardiovascular Cooperative: Supporting Cardiovascular Risk Reduction in Primary Care
Co-Investigator (Cherrington PI)
$4,500,000

6/1/19 – 5/31/22
Drug Effectiveness Review Project (Oregon Health and Science University)
Comparative Effectiveness Review – master contract
PI
Up to $500,000 (topics individually contracted)

8/18/15 – 3/31/24
National Institutes of Health – National Center for Advancing Translational Sciences
Grant No. UL1TR001417
UAB Center for Clinical and Translational Research (CCTS)
Auburn – Partner Network Investigator 1.45 CM (Kimberly PI)

7/1/16 - 6/30/20
National Institutes of Health; Grant No. 2R01GM097618-04
Machine Learning for Adverse Drug Events
Subcontract PI (University of Wisconsin prime - Page)
$635,376 (Auburn subcontract)

9/30/15 - 9/29/20
U.S. Food and Drug Administration; Contract No. FDA BAA-13-0019
Comparative Surveillance of Generic Drugs by Machine Learning
Subcontract PI (Marshfield Clinic Research Foundation prime - Peissig)
$519,736 (Auburn subcontract)


Teaching:

PYPC 7840 Pharmaceutical Economics, Outcomes, and Policy (Fall)
PYPC 7830 Pharmacoepidemiology (Spring)
PYPP 5970 Special Problems - Research Methods (Fall)
PYPC 7950/8950 Pharmacy Care Systems Graduate Seminar (Fall/Spring)
PYPC 5110 Law and Ethics (Spring)


Recent and Current Graduate Students:

Shahariar Mohammed Fahim (PhD student)
Md Motiur Rahman (PhD 2020)
Ning Cheng (PhD 2020)
Yasser Alatawi (PhD 2019)
Saranrat Wittayanukorn (PhD 2015)
Kalyani Sonawane (PhD 2015)


Selected Publications
  • Hohmann NS, Hastings TJ, Jeminiwa RN, Qian J, Hansen RA, Ngorsuraches S, Garza KB. Patient preferences for medication adherence financial incentive structures: A discrete choice experiment. Research in Social and Administrative Pharmacy. 2021 (epub ahead of print).
  • Mishuk AU, Chen L, Li C, Huo N, Hansen RA, Harris I, Kiptanui Z, Qian J. Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study. Current Medical Research and Opinion. 2021 (epub ahead of print).
  • Hohmann NS, Poudel N, Garza KB, Surry D, Hansen RA, Harris I, Kiptanui Z, Oguntimein O, Frost MM, Qian J. Patient and caregiver opinions about an FDA-developed generic drug educational handout: a pilot cross-sectional survey. Journal of the American Pharmacist Association. 2020 (epub ahead of print).
  • Alatawi Y, Hansen RA, Chou C, Qian J, Suppiramaniam V, Cao G. The impact of cognitive impairment on survival and medication adherence among older women with breast cancer. Breast Cancer. 2020 (epub ahead of print).
  • Chou C, McDaniel CC, Abrams JD, Farley JF, Hansen RA. An examination of prescribing responsibilities between psychiatrists and primary care providers. Psychiatry Quarterly. 2020 (epub ahead of print).
  • Chen L, Li C, Huo N, Mishuk AU, Hansen RA, Harris I, Kiptanui Z, Qian J. Oral generic tacrolimus initiation and substitution in the Medicaid population: a new user cohort study. Current Medical Research and Opinion. 2020 (epub ahead of print).
  • Li C, Chen L, Huo N, Mishuk AU, Hansen RA, Harris I, Kiptanui Z, Wang Z, Qian J. Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study. PloSone. 2020; 15(4):e0232226.
  • Alatawi Y, Hansen RA, Chou C, Qian J, Suppiramaniam V, Cao G. The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer. European Geriatric Medicine. 2020; 11(6):1017-26.
  • Rahman MM, Howard G, Qian J, Garza K, Abebe A, Hansen RA. Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study. Research in Social and Administrative Pharmacy (epub ahead of print).
  • Huo N, Chen L, Ulluh Mishuk A, Li C, Hansen RA, Harris I, Kiptanui Z, Wang Z, Dutcher SK, Qian J. Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study. Endocrine. 2020; 68(2):336-48.
  • Gamston CE, Kirby AN, Hansen RA, Redden D, Whitley HP, Hanson C, Lloyd KB. Comparison of 3 risk factor-based screening tools for the identification of prediabetes. Journal of the American Pharmacist Association. 2020; 60(3):481-84.
  • Hohmann NS, Garza KB, Surry D, Hansen RA, Harris I, Kiptanui Z, Oguntimein O, Frost MM, Qian J. Healthcare provider opinions about generic drug educational newsletter: A pilot cross-sectional survey. Research in Social and Administrative Pharmacy. 2020; 16(9):1228-36.
  • Chou C, Hohmann NS, Hastings TJ, Li C, McDaniel CC, Maciejewski ML, Farley JF, Domino ME, Hansen RA. How comfortable are primary care physicians and oncologists prescribing medications for comorbidities in patients with cancer? Research in Social and Administrative Pharmacy. 2020; 16(8):1087-94.

Last Updated: March 02, 2021